CNBC Fast Money Podcast Summary: “Semis Slide, Oil Climbs, Nike Results on Deck… And The Latest Use Case For GLP-1’s”

Air Date: March 30, 2026
Host: Melissa Lee
Panel: Tim Seymour, Guy Adami, Katie Stockton (Fairlead Strategies, guest technician)
Guest Analysts: Julian Emanuel (Evercore ISI), Jared Holz (Mizuho)

Episode Overview

This episode dives into a turbulent start for markets with a sharp reversal in semiconductor stocks, analyzes the latest surge in commodities amid Middle East tensions, previews Nike’s highly anticipated earnings, discusses the volatile state of major financials like American Express, and explores the expanding use cases for weight-loss drugs (GLP-1s), especially Eli Lilly’s AI-powered R&D push. The team also debates market breadth, sector rotation, the safe-haven bid for bonds, and the evolving landscape in both tech and consumer sectors.

1. Semiconductor “Chipwreck” – Sector Slides Into Correction

[01:51–07:08, 13:38–14:19]

Key Points

• Semiconductors, led by the SMH ETF, plunged over 3%, with memory names (Micron, Sandisk, Seagate, Western Digital) suffering deep drops after a strong open.
• Major names like Nvidia, AMD, Intel, and Broadcom were not spared; Intel dropped over 4%.
• Panelists debated whether the sharp moves reflect short-term volatility or a cyclical top.

Analysis & Insights

• Tim Seymour [02:32]:
  “Even while Nvidia has kind of stalled and passed the torch to other parts of the semiconductor chain, it has still been a place where you’re getting the growth... I think it’s absolutely a concern market leadership in terms of market weights.”
• Guy Adami [03:34]:
  “Micron is down 32% since they reported earnings…maybe that quarter was as good as it gets and maybe these memory names are still cyclical.”
• Katie Stockton [04:10]:
  “This is a shift that’s notable…now we have this whole subsegment of semiconductors that are starting to lag. It’s a meaningful shift and it’s something that’s carried over to the broader space.”

Technical Takeaways

• Katie Stockton [06:36]:
  “They tend to all bottom around the same day…we really need the top down influence, look at the S&P 500. With the MACD’s rolling on weekly charts, that’ll take some time.”

2. Bonds & Safe Haven Flows Amid Growth Concerns

[07:08–10:30, 24:46–25:52]

Key Points

• An intraday bid for bonds as stocks declined and oil surged, suggesting a flight to quality.
• Treasury yields’ movement debated, with some warning of further yield rises (which would hurt growth and valuations).

Notable Quotes

• Tim Seymour [07:25]:
  “If we really are having a growth scare out there, Treasuries should see a flight to quality. Jerome Powell…gave a lot of confidence to the bond market…that shocks are short term phenomenons.”
• Guy Adami [09:01]:
  “There’s been no meaningful bounce in the TLT at all…if 10 year yield goes north of 4.6%, that will not be good.”

Takeaway

Bonds are finally showing safe-haven characteristics after months of uncertainty, but long-term concerns linger on yields and growth.

3. Markets Near Inflection; Breadth Weakens

Special Guest: Julian Emanuel (Evercore ISI) [10:30–14:19]

Key Insights

• “The bullish case for stocks lies solely on getting the oil price down,” said Julian Emanuel [10:41].

• Despite war-driven volatility, key parts of the market (credit, tech, alternative asset managers) have held up well.

• Potential for buying opportunity if indices test further support, especially with hedging already elevated across assets.

• Julian Emanuel [13:38]:
  “The names that you mentioned are trading at valuations below their pandemic troughs…these are the names that if the economy slows down you’re still going to get the earnings at a price that’s very attractive.”

• On Mag 7: Time to cautiously add large cap tech, but market psychology may be shifting and support levels need confirmation.

Breadth Discussion

• Guy Adami [17:27]:
  “26% of all stocks are 40% lower than their 52 week…all time highs. How is it possible the broader market is just down 9%, when 1 in 4 stocks are down that much?”
• Implies major concentration risk in index performance.

4. Commodities: Oil & Aluminum Surging on Geopolitics

Commodity Segment with Pippa Stevens [19:03–21:37]

Key Points

• WTI crude closes above $100 for the first time since 2022 amid ongoing Iran-Israel war and attacks on smelters in the Middle East.
• Aluminum prices spike due to supply hits.
• McDonald’s and large consumer brands may face pressure from rising energy.

Analyst Takes

• Guy Adami [20:47]:
  “Maybe there’s something we should be paying more attention to in terms of rotation out of energy and other things.”

• Tim Seymour [21:37]:
  “I’d rather own the inputs…like a Rio Tinto or BHP.”

• Commodities likely in a longer-term bull cycle, but energy could see short-term exhaustion.

5. Financials: Bank & Card Giants in Focus

[24:46–27:34]

Key Points

• XLF (Financials ETF) remains in a pronounced downtrend.
• Wells Fargo bullish on American Express (AXP) for its affluent client base.
• Citibank discussed as a potential value play, especially ahead of earnings.

Panelist Views

• Guy Adami [25:15]:
  “I get the affluent customer…not sure that’s enough. If credit defaults pick up, it will make its way into the higher end.”
• Katie Stockton [25:40]:
  “No shift yet…no momentum to see discovery. So, to me, it’s early [for AXP].”
• Tim Seymour [25:52]:
  “You’re trying to buy selective weakness in banks, assuming we’re not going into an epic growth scare.”

6. Nike Earnings Preview: Can the Swoosh Bounce?

[29:30–31:46]

Key Points

• Nike at 8-year lows, down 22% since last report; investors eyeing major turnaround signals.
• Inventories have cleaned up, but China/digital remain issues.

Panelist Opinions

• Tim Seymour [29:47]:
  “I think you buy it…I’m not telling you it can’t go lower…North America was up 9% last quarter.”
• Guy Adami [30:47]:
  “Competition is fierce. Valuation is OK…there’s further decline here in Nike.”
• Katie Stockton [31:17]:
  “Very interesting…when you come into an earnings report this oversold, more likely to see a positive reaction. Nike has support around $50.”

7. Pharma: Eli Lilly’s AI Push & Expanding GLP-1 Use

Special Guest: Jared Holz (Mizuho) [33:16–39:16]

Key Topics

• Eli Lilly invests $2.75 billion in Hong Kong’s Insilico for AI-driven drug discovery.
• Baseline Therapeutics and Lilly are testing GLP-1 drugs for substance abuse/addictions, not just weight loss.
• Market is not yet pricing in these wider use-cases—so far, only weight loss is in consensus models.

Notable Quotes

• Jared Holz [34:07]:
  “There’s no question the drugs will work to some degree…we know it works for food, I think it works for anything—alcohol, smoking, anything where there’s intake.”
• Jared Holz [35:48]:
  “This is probably the most under heralded, amazing drug launch [Novo’s Wegovy oral] that we’ve ever seen…yet there’s all this fanfare around [Lilly’s] Orforglipron.”
• On Merck and M&A [38:02]:
  “If you’re going to spend $15 billion a year on R&D, at some point you have to show something…Can’t really remember the last time Merck internally developed a blockbuster.”

Chart Watch

• Katie Stockton [39:16]:
  “Lilly still in a long-term uptrend—buy into weakness, but no short-term countertrend signals yet.”

8. Meta (Facebook) Breakdown

[41:29–43:39]

Summary

• Meta pops 2% but remains deeply in a technical downtrend, breaking key support levels.
• Katie Stockton [41:45]:
  “Long-term topping formation…most recently broke some support at the November low…additional support around $500.”
• Panel debates: Is this Meta’s “tobacco moment”? Most think it’s an overdone headline risk, but chart remains bearish for now.

9. McDonald’s Bets on K-Pop & Consumer Shifts

[44:26–46:17]

• McDonald’s launches K-pop themed Demon Hunters meals, aiming to attract younger consumers, as rising gas prices risk eating into lower-income spending.
• Tim Seymour [45:19]:
  “No one markets better than McDonald’s…feel good about owning in a tough environment.”
• Guy Adami [45:38]:
  “Moves of this magnitude to the downside have happened many times; valuation always a little stretched, but not ridiculous.”
• Katie Stockton [46:07]:
  “Long-term steady uptrend—good long-term hold, maybe not best entry right here.”

10. Final Trades [46:41–47:15]

• Tim Seymour: “Pharma stocks breaking out…”
• Katie Stockton: MOO ETF (Agribusiness) – shows strong relative strength vs. S&P 500.
• Guy Adami: Agnico Eagle Mines (Gold miner), also a shout-out to in-studio fans.

Memorable Quotes & Moments

• On Market Breadth – Guy Adami [17:27]:
  “26% of all stocks are 40% lower than their 52 week highs…How is it possible the broader market is just down 9%, when 1 in 4 stocks are down that much?”
• On GLP-1 Drugs – Jared Holz [34:07]:
  “We know it works for food, I think it works for anything: alcohol, smoking…anything where there’s intake.”
• On Oil’s Market Power – Julian Emanuel [10:41]:
  “The bullish case for stocks lies solely on getting the oil price down.”

Timestamps of Notable Segments

• Semis/Chipwreck Begins: 01:51
• Bond Safe-Haven Flows: 07:08
• Julian Emanuel Market Outlook: 10:30
• Commodity/Oil Surge: 19:03
• Financials/AXP discussion: 24:46
• Nike Earnings Preview: 29:30
• GLP-1/Pharma Innovations (Jared Holz): 33:16
• Meta Selloff/FB Chart: 41:29
• McDonald’s K-Pop Tie-In: 44:26
• Final Trades: 46:41

Summary

This episode of Fast Money was dense and energetic, dominated by a major reversal in semis, concerns over cyclical leadership, and nervous upside action in bonds and commodities amid geopolitical strife. Nike’s deeply oversold setup ahead of earnings drew mixed views. Meanwhile, pharma innovation (especially new AI and GLP-1 advances) and the crowded state of sector leadership were key focal points. The show ended with a look at new consumer strategies (McDonald’s K-Pop meals) and final actionable ideas, maintaining Fast Money’s rapid-fire, actionable tone.